QuidelOrtho Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Brian Blaser
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt
Sep 15
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry
Aug 09QuidelOrtho: Attractive Valuation Despite Weak Performance
Apr 13We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
Apr 08QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues
Feb 15QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate
Mar 13QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Feb 18An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued
Nov 25QuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours
Oct 12QuidelOrtho: Fundamentals Remain, Upbeat Financials
Sep 14Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet
Sep 03QuidelOrtho announces $300M share repurchase authorization
Aug 17Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)
Aug 13Quidel Non-GAAP EPS of $2.34 misses by $0.51, revenue of $613.4M misses by $27.21M
Aug 04QuidelOrtho: Continuing Its Upward Ascent
Jul 08CEO
Brian Blaser (59 yo)
less than a year
Tenure
Mr. Brian J. Blaser serves as CEO & President at QuidelOrtho Corporation since May 06, 2024 & serves as it's Director since May 15, 2024. He served as an Independent Director at Quanterix Corporation since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 2.5yrs | US$2.94m | 0.018% $ 463.6k | |
| Executive VP & COO | 4.2yrs | US$3.41m | 0.067% $ 1.7m | |
| Executive Officer | 10.5yrs | US$2.03m | 0.054% $ 1.4m | |
| Executive VP & Chief Commercial Officer | less than a year | US$3.32m | 0.025% $ 646.5k | |
| President | less than a year | no data | no data | |
| Executive VP of Research & Development and CTO | less than a year | no data | no data | |
| Vice President of Investor Relations | 1.2yrs | no data | no data | |
| Senior VP | 3.9yrs | US$3.55m | 0.021% $ 542.3k | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Point of Care Business Unit Leader | no data | no data | no data | |
| Molecular Diagnostics Business Unit Leader | no data | no data | no data |
1.2yrs
Average Tenure
57.5yo
Average Age
Experienced Management: QDEL's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | no data | |
| Independent Director | 4.3yrs | US$314.47k | 0.012% $ 315.8k | |
| Independent Director | 10yrs | US$320.47k | 0.042% $ 1.1m | |
| Independent Non-Executive Chairman | 17yrs | US$411.50k | 0.13% $ 3.4m | |
| Independent Director | 5.9yrs | US$326.94k | 0.023% $ 609.9k | |
| Independent Director | 31.8yrs | US$300.95k | 0.035% $ 913.4k | |
| Independent Director | 2.5yrs | US$286.95k | 0.0077% $ 202.4k | |
| Independent Director | 6.6yrs | US$280.00k | 0.044% $ 1.1m | |
| Independent Director | 2.5yrs | US$70.00k | no data | |
| Independent Director | 3.8yrs | US$280.00k | 0.0098% $ 255.5k | |
| Independent Director | less than a year | US$110.83k | 0.0023% $ 59.0k |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: QDEL's board of directors are considered experienced (4.3 years average tenure).